Tech Company Financing Transactions
Stellanova Therapeutics Funding Round
Stellanova Therapeutics secured a $15.5 million Series A financing round on 6/7/2021. Investors included Sporos Bioventures and private investors.
Transaction Overview
Company Name
Announced On
6/7/2021
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series A
Investors
Sporos Bioventures (Lead Investor) (Harold Levy)
Proceeds Purpose
Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by fibroblasts in the tumor microenvironment, rendering resistant cancers treatable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2450 Holcombe Blvd. J
Houston, TX 77021
USA
Houston, TX 77021
USA
Phone
Undisclosed
Website
Email Address
Overview
Stellanova Therapeutics is developing the first cancer therapies targeting cancer-associated fibroblasts (CAFs) and their symbiotic interactions within the tumor microenvironment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emmanuelle Schuler
Chief Scientific Officer
Jeno Gyuris
Co-Founder
Rosa Hwang
Founder
Ronald DePinho
Browse more venture capital transactions:
Prev: 6/4/2021: Sharpen Technologies venture capital transaction
Next: 6/7/2021: Hungryroot venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs